Content » Vol 69, Issue 146

Clinical trial with cyclosporin A

A Cimitan, F Fantini, A Giannetti
DOI: 10.2340/0001555569146159163


Six male patients with extensive psoriasis, resistant to conventional treatment, were treated orally with low-dose Cyclosporin A (CsA) (5 mg/kg/day). One patient had generalized pustular psoriasis, three psoriatic erythroderma, and two disseminated chronic plaque psoriasis. All patients, with the exception of one, were treated for at least twelve weeks. Nearly complete remission was obtained in four cases. In one patient the response was incomplete, while treatment in one case was suspended after two weeks because of the onset of cutaneous pyogenic infections and oral candidiasis. In each case a relapse was observed with the suspension of treatment.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.